Robert Paul Myers insider trades
Open-market stock purchases and sales by Robert Paul Myers, Chief Medical Officer at Mirum Pharmaceuticals, Inc, from SEC Form 4 filings since Oct 9, 2026.
Companies traded
- MIRM Mirum Pharmaceuticals, Inc: other filings, last Oct 9, 2026